Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia.

Lentinula edodes

OncologyImmune supportGut & microbiome

SpeciesShiitake, Hua Gu

JournalIntegrative cancer therapies

Year2022

Metadata-grounded summary

Article summary

Metadata-grounded summary: This clinical trial indexes research on Lentinula edodes in Integrative cancer therapies in 2022. MycoData maps the paper to oncology, immune support, gut & microbiome based on its title, species context, article metadata, and study classification.

Citation

Kamiyama T, Orimo T, Wakayama K, Kakisaka T, Shimada S, Nagatsu A, et al. (2022). Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia. Integrative cancer therapies https://doi.org/10.1177/15347354211073066 PMID: 35075934

Open citation